Home NDC 0555-0096-96 Clonazepam
Product NDC 0555-0096
Requested package NDC 0555-0096-96
11-digit product format 005550096
Labeler code 0555
Product ID 0555-0096_88de80cf-d6e8-4e9d-87d7-6febf7b245d4
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Clonazepam
Dosage form TABLET, ORALLY DISINTEGRATING
Route ORAL
Labeler Teva Pharmaceuticals USA, Inc.
Application ANDA077194
Marketing category ANDA
Marketing start 2005-08-11
Marketing end 0000-00-00
Substance CLONAZEPAM
Active strength 1 mg/1
Pharmacologic classes Benzodiazepine [EPC],Benzodiazepines [CS]
DEA schedule CIV
NDC exclude flag No
Listing certified through 2022-12-31
Current FDA listing Historical FDA.report record
Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 12 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 5 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A077194-001 CLONAZEPAM CLONAZEPAM 0.125MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2005-08-10 A077194-002 CLONAZEPAM CLONAZEPAM 0.25MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2005-08-10 A077194-003 CLONAZEPAM CLONAZEPAM 0.5MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2005-08-10 A077194-004 CLONAZEPAM CLONAZEPAM 1MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2005-08-10 A077194-005 CLONAZEPAM CLONAZEPAM 2MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2005-08-10
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 5 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 6 · 225 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 A077194-001 CLONAZEPAM 0.125MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2005-08-10 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A077194-002 CLONAZEPAM 0.25MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2005-08-10 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A077194-003 CLONAZEPAM 0.5MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2005-08-10 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A077194-004 CLONAZEPAM 1MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2005-08-10 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A077194-005 CLONAZEPAM 2MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2005-08-10 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 A077194-001 CLONAZEPAM 0.125MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2005-08-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 A077194-002 CLONAZEPAM 0.25MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2005-08-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 A077194-003 CLONAZEPAM 0.5MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2005-08-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 A077194-004 CLONAZEPAM 1MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2005-08-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 A077194-005 CLONAZEPAM 2MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2005-08-10 c2088c7a36db…2026-09-14 22:38:34 2026-08 A077194-001 CLONAZEPAM 0.125MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2005-08-10 84e616aacf4f…2026-09-14 22:38:34 2026-08 A077194-002 CLONAZEPAM 0.25MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2005-08-10 84e616aacf4f…2026-09-14 22:38:34 2026-08 A077194-003 CLONAZEPAM 0.5MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2005-08-10 84e616aacf4f…2026-09-14 22:38:34 2026-08 A077194-004 CLONAZEPAM 1MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2005-08-10 84e616aacf4f…2026-09-14 22:38:34 2026-08 A077194-005 CLONAZEPAM 2MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2005-08-10 84e616aacf4f…2026-08-18 06:07:40 2026-07 A077194-001 CLONAZEPAM 0.125MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2005-08-10 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A077194-002 CLONAZEPAM 0.25MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2005-08-10 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A077194-003 CLONAZEPAM 0.5MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2005-08-10 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A077194-004 CLONAZEPAM 1MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2005-08-10 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A077194-005 CLONAZEPAM 2MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2005-08-10 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A077194-001 CLONAZEPAM 0.125MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2005-08-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A077194-002 CLONAZEPAM 0.25MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2005-08-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A077194-003 CLONAZEPAM 0.5MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2005-08-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A077194-004 CLONAZEPAM 1MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2005-08-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A077194-005 CLONAZEPAM 2MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2005-08-10 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A077194-001 CLONAZEPAM 0.125MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2005-08-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A077194-002 CLONAZEPAM 0.25MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2005-08-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A077194-003 CLONAZEPAM 0.5MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2005-08-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A077194-004 CLONAZEPAM 1MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2005-08-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A077194-005 CLONAZEPAM 2MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2005-08-10 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A077194-001 CLONAZEPAM 0.125MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2005-08-10 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A077194-002 CLONAZEPAM 0.25MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2005-08-10 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A077194-003 CLONAZEPAM 0.5MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2005-08-10 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A077194-004 CLONAZEPAM 1MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2005-08-10 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A077194-005 CLONAZEPAM 2MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2005-08-10 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A077194-001 CLONAZEPAM 0.125MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2005-08-10 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A077194-002 CLONAZEPAM 0.25MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2005-08-10 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A077194-003 CLONAZEPAM 0.5MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2005-08-10 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A077194-004 CLONAZEPAM 1MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2005-08-10 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A077194-005 CLONAZEPAM 2MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2005-08-10 fd3edfee7708…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 6 · 225 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded CLONAZEPAM ACTIVE INGREDIENT 5PE9FDE8GB CLONAZEPAM TABLET, ORALLY DISINTEGRATING [BARR LABORATORIES INC.] 7 CLONAZEPAM ACTIVE MOIETY 5PE9FDE8GB CLONAZEPAM TABLET, ORALLY DISINTEGRATING [BARR LABORATORIES INC.] 7 ASPARTAME INACTIVE INGREDIENT Z0H242BBR1 CLONAZEPAM TABLET, ORALLY DISINTEGRATING [BARR LABORATORIES INC.] 7 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U CLONAZEPAM TABLET, ORALLY DISINTEGRATING [BARR LABORATORIES INC.] 7 CROSPOVIDONE INACTIVE INGREDIENT 68401960MK CLONAZEPAM TABLET, ORALLY DISINTEGRATING [BARR LABORATORIES INC.] 7 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 CLONAZEPAM TABLET, ORALLY DISINTEGRATING [BARR LABORATORIES INC.] 7 MANNITOL INACTIVE INGREDIENT 3OWL53L36A CLONAZEPAM TABLET, ORALLY DISINTEGRATING [BARR LABORATORIES INC.] 7 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 CLONAZEPAM TABLET, ORALLY DISINTEGRATING [BARR LABORATORIES INC.] 7 SODIUM STEARYL FUMARATE INACTIVE INGREDIENT 7CV7WJK4UI CLONAZEPAM TABLET, ORALLY DISINTEGRATING [BARR LABORATORIES INC.] 7 XYLITOL INACTIVE INGREDIENT VCQ006KQ1E CLONAZEPAM TABLET, ORALLY DISINTEGRATING [BARR LABORATORIES INC.] 7
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Clonazepam CLONAZEPAM Teva Pharmaceuticals USA, Inc. cb2e209e-e69b-422b-8abb-34df2bc92caa 2024-05-14 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 077194 application number: ANDA077194
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 0555-0096-96 00555009696 10 BLISTER PACK in 1 CARTON (0555-0096-96) > 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK 10 blister pack 2005-08-11 0000-00-00 No No Current